Does insurance cover Wegovy®? Check your coverage in 2026

Wegovy^® is one of the most talked-about prescription medications. It’s considered one of the most effective weight-loss medications available today, helping many people lose an average of 15% of body weight when used alongside lifestyle changes. 

Wegovy^® was approved for weight loss in 2021 as a once-weekly injection. In January 2026, the oral version of Wegovy^® became the first GLP-1 pill approved for weight loss.

While both versions of Wegovy^® can be helpful for weight loss, one of the big questions people have is about the price. 

Without insurance, the retail cost is typically around $1,350 per month for both forms. The challenge is that many insurance plans don’t cover medications specifically prescribed for weight management, even when they cover the same medication for other conditions. 

While Wegovy^® may be covered for certain medical uses, like heart disease or MASH, weight loss—the reason most people seek it out—is the least likely.

Why? The big reason is that U.S. insurance rules don’t require plans to cover medications specifically prescribed for weight loss. That policy dates back decades, when weight-loss drugs were viewed as lifestyle treatments rather than therapies for a chronic disease.

As a result, even though newer medications like GLP-1 drugs treat obesity and related health risks, insurers are still allowed to leave them off their formularies (covered lists of medications), which is why coverage can be inconsistent or unavailable.

Let’s go through how Wegovy^® coverage works across major insurance plans, why approvals are sometimes denied, how state and federal policies affect access, and what the medication typically costs with and without insurance. 

You’ll also learn the key factors insurers look at during prior authorization and the practical steps you can take to check your own coverage.

Is Wegovy^® ever covered by insurance?

Yes, Wegovy^® might be included under your insurance plan, but having a plan that “includes” Wegovy^® and actually getting it approved are two different things. Most plans exclude weight loss medications as a benefit category, but it might be covered for another use, like heart disease or MASH (metabolic dysfunction–associated steatohepatitis). 

Approval almost always depends on your plan’s benefit structure and the reason your doctor prescribed it. Insurers evaluate each request individually, and the documentation your provider submits plays a major role in the outcome.

Coverage can be denied if the documentation doesn’t meet the insurer’s threshold for medical necessity or if the insurer requires step therapy with a different medication first.

Wegovy® insurance coverage by plan type

Wegovy^® coverage often depends on whether you have private insurance or a government program like Medicare or Medicaid. Private plans—usually provided through an employer or purchased on the marketplace—set their own coverage rules, while government programs follow federal or state policies that can limit whether weight-loss medications are covered at all. 

Across both types of plans, insurers typically require prior authorization (PA) and other approval steps, meaning your doctor must submit medical documentation showing that the medication is medically necessary before the plan agrees to pay for it. Below is a summary of how the largest insurers and pharmacy benefit managers typically handle Wegovy^®.

Wegovy® coverage: Private insurance plans 

Insurance coverage for Wegovy^® can look very different depending on your insurer and the specific plan you’re enrolled in. Each plan maintains a list of medications the insurer has approved for coverage and how they’re paid for, which determines whether Wegovy® is included and what requirements apply. The chart below shows how several major insurers typically handle coverage, along with common requirements like prior authorization and BMI criteria—though exact policies can still vary by employer plan or state.

Insurance provider	Coverage status	Requirements	Comments	State variation
Aetna	Wegovy® may be covered for weight management, depending on your exact benefits. Cardiovascular risk reduction use follows standard prior authorization (PA) pathways.	PA required. BMI ≥30 or ≥27 with comorbidity. Prior lifestyle intervention documentation is often needed.	CVS Caremark manages pharmacy benefits for many Aetna members. Formulary placement varies.	Yes
Blue Cross Blue Shield (BCBS)	Coverage differs significantly by state affiliate. Some BCBS plans have restricted or excluded GLP-1 weight loss coverage in 2026.	PA mandatory. Documentation of BMI, diagnosis, and failed lifestyle changes is required.	Each state BCBS sets independent formulary rules. Federal employee plans carry separate cost structures.	Yes
Cigna	Covered for medically necessary weight management on many formularies. Cardiovascular indication is also covered.	PA and QL standard. Step therapy may require trying other medications first.	Cigna has tightened utilization management for GLP-1s. Employer plan exclusions are common.	Yes
UnitedHealthcare	Available on formularies for weight management and cardiovascular use. Coverage depends on employer group.	PA required. Documented BMI criteria and clinical notes needed.	OptumRx processes pharmacy claims and manages formulary placement. Some plans exclude GLP-1 weight management medications entirely unless the employer has opted into coverage.	Yes
Kaiser Permanente	Covered within Kaiser’s internal formulary for approved indications. Regional variation exists.	Internal PA process. Lab work and documented medical history required.	Kaiser’s closed pharmacy system means formulary decisions are tightly controlled.	Yes
Humana	Available for approved indications on many formularies. Weight management coverage depends on benefit design.	PA and QL apply. Prior documentation of diagnosis and BMI required.	Humana Medicare Advantage plans follow Part D rules; commercial plans vary.	Yes
Anthem	Wegovy may be listed on some Anthem commercial formularies, but coverage is highly dependent on employer-sponsored benefits. Many plans exclude Wegovy for weight management entirely, even when FDA-approved.	Prior authorization (PA) is required when covered, including diagnosis codes, BMI criteria, and supporting clinical documentation.	Anthem operates under different names by state, and Wegovy coverage varies by region, employer plan, and formulary design. Exclusions for weight-loss use are common in 2026.	Yes
Molina Healthcare	State-dependent. Coverage is determined by state Medicaid programs and marketplace plan design. Wegovy® and other weight-loss medications are often excluded from coverage.	PA required. Step therapy and formulary rules are set by the state Medicaid contract.	Molina primarily serves Medicaid and marketplace populations, so coverage varies widely by state and plan. Always check your specific state formulary.	Yes
Ambetter	State marketplace plan coverage varies. Approved indication access depends on state and plan tier.	Prior authorization (PA) and quantity limits (QL) are typical. Step therapy may apply based on plan requirements.	Managed by Centene. Formulary and benefit design differ by state.	Yes
Oscar Health	Wegovy® may be listed on select formularies, but coverage for weight management is highly plan-dependent and often restricted or excluded based on benefit design.	PA required. BMI records and clinical documentation needed.	Smaller footprint means fewer standardized policies. Confirm with your specific plan.	Yes
CVS Caremark (PBM)	Formulary inclusion for Wegovy® is determined by the employer or plan sponsor, and coverage varies widely based on benefit design. Wegovy may be available for approved uses, but access is often restricted or excluded for weight management.	Prior authorization (PA), step therapy, and other utilization management tools are administered by CVS Caremark on behalf of the plan.	CVS Caremark is a pharmacy benefit manager, not an insurer. Coverage rules reflect the plan sponsor’s decisions rather than a standardized policy.	Yes
Express Scripts (PBM)	Wegovy® may be included on many managed formularies, but coverage and access for weight management depend on the employer or plan sponsor’s benefit design and may be restricted or excluded.	Prior authorization (PA), quantity limits (QL), and step therapy are commonly applied, along with other utilization management requirements.	Express Scripts manages pharmacy benefits for Cigna and other large employers. Coverage policies reflect sponsor decisions rather than a standardized rule.	Yes

This table reflects publicly available plan information as of February 2026. Coverage policies change regularly—always verify with your specific plan before making treatment decisions.

Wegovy® coverage: Federal Medicare insurance plans

Federal health programs follow a different set of rules than private insurance, so coverage for Wegovy^® can look a little different here. The chart below shows how the two major federal programs—Medicare and TRICARE—generally handle coverage, including when the medication may be approved and what requirements typically apply.

Insurance provider	Coverage status	Requirements	Comments	State variation
Medicare (Part D)	Not covered for weight loss alone due to federal law. Coverage is allowed when Wegovy® is prescribed for an FDA-approved indication, such as cardiovascular risk reduction.	Must meet indication-specific criteria. Prior authorization (PA), formulary placement, and cost-sharing vary by Part D plan.	A CMS demonstration program beginning in 2026 may expand limited access to GLP-1 medications at reduced cost, but this operates outside standard Part D coverage and does not represent full coverage expansion.	No (federal)
Tricare	Limited coverage for weight management. May cover for cardiovascular risk reduction.	PA and documented medical necessity required.	Military formulary is managed centrally. Check the Tricare formulary search tool.	No (federal)

Wegovy coverage: State Medicaid insurance plans

Medicaid coverage for Wegovy^® can vary depending on where you live. Because each state manages its own Medicaid program, policies around GLP-1 medications—including whether they’re covered for weight management—can differ significantly from one state to another. The chart below summarizes the general landscape.

Insurance provider	Coverage status	Requirements	Comments	State variation
Medicaid	State-dependent. Many programs cover cardiovascular indications. Weight-management-only coverage is limited.	State-specific PA requirements. Preferred drug list placement varies.	Each state runs its own program. Several states restricted GLP-1 weight loss coverage in 2026.	Yes

Dosing can also affect coverage and cost. For a detailed look at how Wegovy^® dosing works, see our complete dosage guide here: Wegovy^® Dosage Guide.

State-by-state coverage for Wegovy^®

Your state can have a real impact on what you pay for Wegovy^® —particularly through Medicaid, where every state writes its own rules. Several states adjusted their GLP-1 coverage policies heading into 2026, and those changes are still playing out.

Here are some of the most notable state-level differences:

State	What’s different here?
California	Wegovy® is no longer covered under the Medi-Cal Rx Contract Drugs List (CDL) for weight loss or weight-related indications. Claims for Wegovy® are denied regardless of indication, and previously approved prior authorizations are no longer valid.Coverage may be considered only on a case-by-case basis for specific non–weight loss indications, such as cardiovascular disease or noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), subject to individual review.
New York	NYRx provides limited coverage for Wegovy® under strict clinical criteria, including confirmed cardiovascular disease, BMI ≥40, and participation in lifestyle modification. Coverage is not available for general weight management and is subject to quantity limits and prior authorization. Requirements may still vary across managed care plans.
Texas	Texas Medicaid applies clinical PA for Wegovy® for at least certain covered indications (e.g., MASH). Weight-management coverage remains plan/PDL-dependent and should be verified through the Texas Medicaid drug formulary/PDL or the member’s MCO.
Florida	Coverage must be verified against the current Florida Medicaid Preferred Drug List (PDL). Weight-loss GLP-1 coverage is commonly restricted in Medicaid, but Florida-specific Wegovy status should be confirmed in the PDL for 2026.
Pennsylvania	As of early 2026, Medicaid coverage for weight-loss-only GLP-1 prescriptions has been restricted. Coverage for cardiovascular and other approved indications continues with PA.
Illinois	Illinois Medicaid publishes a PDL (effective Jan 27, 2026). Wegovy® is not listed in that PDL document, so coverage should be treated as uncertain and verified via HFS prior approval status tools / plan-specific rules.
Massachusetts	MassHealth added Wegovy® as a preferred anti-obesity agent effective Feb 17, 2026, with BMI/comorbidity criteria and utilization controls (e.g., PA rules depending on setting/class).

Coverage information may vary and change frequently. Always confirm with your state Medicaid office or insurance provider.

What determines Wegovy® insurance coverage?

Every coverage decision runs through a set of filters. Knowing what those filters are gives you a clearer sense of why your claim was approved, denied, or flagged for additional review.

Here are the primary factors at play:

• Benefit design exclusions: Some plans exclude weight management medications as a benefit category because they don’t have to include them. This means it doesn’t matter how strong your medical case is—the plan simply doesn’t cover drugs in that class. 
• FDA-approved indications: Insurers tie their decisions closely to the FDA label, though it’s important to remember that no insurance plans are required to cover weight loss medications. 
• Clinical documentation: What’s in your chart matters. Reviewers look at your diagnosis code, BMI, relevant lab results, and clinical notes. Thorough, specific documentation from your provider strengthens the case.
• Prior authorization: Wegovy^® requires PA under virtually every plan. Your provider submits the clinical rationale, and the insurer’s utilization team evaluates whether the request meets their criteria. If denied, an appeal with additional justification can sometimes reverse the decision.
• Your plan’s approved drug list and preferred alternatives: Your plan’s drug list determines which GLP-1 is preferred. Some insurers favor tirzepatide (Zepbound^®) over semaglutide, or vice versa. If Wegovy^® isn’t the preferred option, you may face step therapy requirements. 
• Medicare and federal policy shifts: Federal guidance continues to evolve. CMS’s pilot program for expanded GLP-1 access, set to begin mid-2026, could change the landscape for Medicare beneficiaries. Wegovy^® ’s negotiated Medicare price of $274/month starting in 2027 will further affect access and affordability under Part D.

These factors interact differently across plans, which is why identical prescriptions can lead to different outcomes depending on the insurer.

How to check if your insurance covers Wegovy^®

Finding out where you stand with coverage usually requires a few specific steps. Here’s a practical checklist:

• Call the member services number on your insurance card
  Ask whether Wegovy^® is covered under your pharmacy benefit and for which medical indication. It can also help to request written confirmation or a link to your plan’s formulary and coverage policy. Many insurers publish their formularies online, so you may be able to review them directly through your insurer’s portal. For example, Medicare Part D plans release updated formularies publicly each year.
  
• Ask about prior authorization (PA)
  Even when Wegovy^® is covered, most insurers require prior authorization. This means your healthcare provider must submit documentation showing that the medication is medically necessary. Ask what information the insurer needs, such as BMI documentation, diagnosis codes, or records of previous treatment attempts.
  
• Check for step therapy requirements
  Some plans also use step therapy. This means you may be required to try other medications or treatments before Wegovy^® will be approved. Ask whether your plan includes a step therapy rule and which medications must be tried first.
• Confirm BMI and medical eligibility criteria
  Coverage for weight management medications usually requires documentation showing:
  • BMI ≥30, or
  • BMI ≥27 with a weight-related health condition, such as high blood pressure or high cholesterol.

The exact criteria and documentation requirements can differ depending on the insurer and, for Medicaid plans, the state program.

• Review Medicare or Medicaid rules (if applicable)
  • Traditional Medicare Part D generally doesn’t cover medications prescribed solely for weight loss, though coverage may be possible if Wegovy® is prescribed for another FDA-approved use, such as cardiovascular risk reduction or MASH.
  • Medicaid coverage varies widely by state, with each program setting its own rules.
    
• Use official coverage tools
  Novo Nordisk offers a manufacturer coverage resource that can help people explore possible insurance pathways and savings options.
  
  You can also use Noom’s Insurance Checker to see whether your plan may cover Wegovy®.
  
• Get everything in writing
  If your insurer approves coverage, denies it, or asks for more documentation, request written confirmation. Having the details in writing can make it easier if you need to submit an appeal later.

If your plan doesn’t cover Wegovy^® but does cover a different GLP-1, it may be worth exploring alternatives. See how Wegovy^® and tirzepatide compare here: Wegovy^® vs Zepbound.

Cost of Wegovy^® with and without insurance

What you actually pay for Wegovy^® depends on your coverage, your dose, and whether you’re using the injection or the pill. The list price for both forms is about $1,350 per month. With commercial insurance and the manufacturer savings card, many people bring that number down to $25 or less. Without insurance, the new cash-pay pricing from Novo Nordisk offers meaningful relief compared to the full list price.

Wegovy^®: Costs with insurance

When Wegovy^® is covered by insurance, many people pay roughly $25 to $150 per month instead of the medication’s full list price. The exact amount depends on your specific insurance plan and how your pharmacy benefits are structured.

For people whose plans include coverage, Wegovy^® is usually placed on a formulary tier (the insurer’s list of covered drugs). Depending on that tier, you may pay either a copay (a flat fee) or coinsurance (a percentage of the drug’s cost). Lower-tier placement generally means lower monthly costs, while higher tiers can result in higher out-of-pocket expenses.

Your cost may also depend on:

• Whether you have met your deductible. If you’re enrolled in a high-deductible health plan, you may need to pay a larger share of the medication’s cost until your deductible is satisfied. After that, your monthly cost typically drops to your plan’s standard copay or coinsurance amount.
  
• Prior authorization approval. Most insurers require documentation showing medical necessity before they agree to cover Wegovy^®. Once approved, coverage follows the cost-sharing rules in your plan.
  
• The prescribed form and dose. Wegovy^® is available as a weekly injection and, more recently, an oral pill. Both are gradually increased over time (a process called titration), and some plans price higher-dose strengths differently. The oral version may also be placed on a different formulary tier, which can affect your cost.
  
• The length of your prescription. Some insurance plans offer lower per-month costs when you fill a 90-day supply instead of a standard 30-day prescription.

While the commonly cited range with insurance is about $25 to $150 per month, individual costs can fall outside that range depending on benefit design, deductible status, the specific Wegovy^® formulation prescribed, and whether manufacturer savings programs apply.

Looking ahead, Novo Nordisk announced in February 2026 that the list price of Wegovy^® will drop to $675 per month starting January 1, 2027—a reduction of approximately 50%. That change will take effect alongside new negotiated Medicare prices of $274 per month under the Inflation Reduction Act. These shifts should meaningfully lower costs for both insured and people who pay cash over time.

Understanding the Wegovy^® Savings Card

If your commercial insurance covers Wegovy^®, the Novo Nordisk savings offer can bring your monthly copay down to as little as $25, with a maximum savings of $100 per fill. The card is valid for people who have insurance coverage and can be used for both the injection and the pill. People on government-funded insurance—Medicare, Medicaid, Tricare—are not eligible.

• How the savings program works: Novo Nordisk offers a manufacturer savings card that lowers your out-of-pocket cost after insurance pays its share. The discount is applied at the pharmacy and can reduce your copay to about $25 per month, depending on your plan and the program’s monthly savings limits.
  
• Who qualifies: The program is generally available to people with commercial (non-government) insurance whose plans already cover Wegovy^®.
  
• Who isn’t eligible: People enrolled in Medicare, Medicaid, TRICARE, VA, or other government-funded insurance programs cannot use the manufacturer savings offer.
  
• How to use it: Enroll through the official Wegovy^® savings program, download the card, and present it with your insurance at the pharmacy so the discount can be applied after your insurance processes the claim.

Even with the savings program, the exact amount you pay depends on your insurance plan, pharmacy benefit rules, and the program’s maximum savings caps.

Wegovy^®: Costs without insurance

If you pay completely out of pocket at a traditional retail pharmacy, Wegovy^® will cost about $1,350 per month for both the weekly injection pens and the daily pill.

But many uninsured people now access lower cash pricing through the NovoCare Pharmacy rather than paying full retail. Under these programs, typical self-pay prices in 2026 are:

Wegovy® pill

• 1.5 mg and 4 mg: $149 per month (4 mg promotional price available through April 15, 2026; then increases to $199/month)
  
• 9 mg and 25 mg: $299 per month
  

Wegovy® injection

• 0.25 mg and 0.5 mg: $199 per month for the first two fills (through March 31, 2026), then $349/month
  
• 1 mg, 1.7 mg, and 2.4 mg: $349 per month

For a full cost comparison across dosing and coverage scenarios, check out our detailed cost guides: Wegovy® cost, Wegovy® pill cost, and Wegovy® dosage guide.

What does Wegovy® cost without insurance? How to navigate pricing in 2026

Frequently asked questions about insurance coverage for Wegovy^®

Coverage rules for Wegovy^® can be confusing. Here are direct answers to the questions people ask most.

Why is Wegovy^® often not covered by insurance?

The most common reason is that your plan excludes weight management medications from its benefits, because weight loss medications aren’t required to be covered by insurance. For government plans like Medicare, federal law has long prevented coverage for medications prescribed only for weight loss. Though that’s starting to change because new programs are beginning to test limited access to these medications.

How can I get insurance to cover Wegovy^®?

Work with your provider to build the strongest possible case. That starts with thorough medical records: a clear diagnosis, documented BMI, relevant lab work, and notes reflecting prior lifestyle interventions. 

Your doctor submits all of this through the prior authorization process. If the initial request is denied, file an appeal—and consider including a letter of medical necessity from your provider explaining why Wegovy^® is the appropriate treatment. Appeals with additional clinical detail frequently succeed where initial submissions didn’t.

How do I get Wegovy^® for $25?

The $25 monthly price is possible when you combine commercial insurance coverage with the Wegovy^® savings offer from Novo Nordisk. The card provides a maximum of up to $100 in monthly savings, which brings many insured people to the $25 copay level, but the exact price you pay will depend on your copay and plan specifications. To qualify, you need active commercial insurance that covers Wegovy^®, and you can’t be enrolled in a government-funded insurance program.

What is the most affordable way to get Wegovy^® without insurance?

For people who are paying out of pocket, the Wegovy^® pill is the more affordable option. The lowest dose is $149 per month. The injection starts at $199 per month.

How much weight can you lose on Wegovy^® in 3 months?

Clinical trials show meaningful weight loss with both forms of Wegovy^®, though results differ slightly between the injection and the pill. 

• Wegovy® injection (2.4 mg weekly): Clinical trials show people lost an average of 6 to 8% of their body weight in the first 12 weeks, with 15 to 17% average weight loss after 68 weeks.
  
• Wegovy® pill (daily): In a 64-week trial, people lost an average of 14% of their body weight on average, and most people lost at least 5%.

Results vary from person to person and depend on factors like dose, diet, activity, and overall health.

The bottom line: Wegovy^® coverage is inconsistent but worth checking 

Insurance coverage for Wegovy® in 2026 happens, but it might require more than a check of what your plan covers. The determining factors—your diagnosis, documented BMI, prior authorization, benefit design, and the form of the medication—all interact to shape what you’ll pay and whether you’ll get approved. Commercial plans with weight management benefits tend to offer the broadest access, while Medicare and Medicaid coverage remains more restrictive, though policy changes are actively underway.

The introduction of the Wegovy® pill has expanded treatment options and brought the cash-pay floor down to $149 per month to start. With Novo Nordisk’s list price reduction to $675 per month taking effect in January 2027, affordability should continue to improve across the board.

If you’re exploring Wegovy®, start by checking your plan’s covered medication list, gathering your medical records, and talking to your provider about the prior authorization process. Whether you’re navigating insurance, considering cash-pay options, or weighing alternatives, the more informed you are, the better positioned you’ll be to make the right decision for your health and your budget. For those looking for a more guided approach, Noom Med can help streamline the process if you qualify. You’ll be connected with a clinician who can help you navigate both insurance and cash-pay options with greater clarity.